ANASTASIA BARTHELEMY: Open Payments
NPI 1891245486 · SEWICKLEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,721 in 158 payments from 23 companies in 2025. Trend: 2023 $1,965 · 2024 $2,628 · 2025 $2,721
Food & beverage: $2,721
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $503 |
| Amgen Inc. | 23 | $347 |
| ABBVIE INC. | 22 | $273 |
| Novo Nordisk Inc | 15 | $255 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 20 | $218 |
| Lilly USA, LLC | 10 | $207 |
| PFIZER INC. | 10 | $182 |
| GlaxoSmithKline, LLC. | 8 | $148 |
| Merck Sharp & Dohme LLC | 5 | $113 |
| Dexcom, Inc. | 5 | $79 |
Products named: FARXIGA, JARDIANCE, OTEZLA, MOUNJARO, QULIPTA, EVENITY, Ozempic, BREZTRI.
Industry payments across PA — which companies pay providers there.
